We hypothesized that in euvolemic or near-euvolemic HF patients with T2DM treated with optimal guideline-recommended therapy, the predictive power of persistent NT-proBNP levels might be far from ideal and that the additional serum levels of irisin could be a powerful prognosticator for long-term prognosis. The gene discussed is FNDC5; the disease is hydrops fetalis.